Iovance Biotherapeutics (IOVA) Return on Assets [ROA] (2011 - 2026)
Iovance Biotherapeutics' Return on Assets [ROA] was -31.44% in Q2 2026, up 10.17 percentage points from -41.61% a year earlier and up 7.04 percentage points from the prior quarter.
Powered by 
Analysis
Iovance Biotherapeutics (IOVA) Return on Assets [ROA] (2011 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at Iovance Biotherapeutics came in at -42.88%, up 1.15 percentage points from FY2024.
- Return on Assets [ROA] shows a five-year change of +3.76 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was -44.02% in FY2024 (+17.46 pp), -61.48% in FY2023 (-6.55 pp), -54.93% in FY2022 (-10.65 pp) and -44.28% in FY2021 (+2.36 pp).
- The Q2 2026 figure marks the highest quarterly Return on Assets [ROA] since Q1 2019.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q1 2025 (a gain of 14.50 percentage points); the worst was Q3 2022 (a drop of 30.38 percentage points).
- Per Business Quant data, IOVA's Return on Assets [ROA] in the three quarters before Q2 2026 was -38.49% (Q1 2026), -43.01% (Q4 2025) and -43.88% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 2.14% |
| 10 | Iovance Biotherapeutics | 6.45 Bn | 5.24 Bn | 55.72 Mn | -31.44% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -31.44% |
| Mar 31, 2026 | -38.49% |
| Dec 31, 2025 | -43.01% |
| Sep 30, 2025 | -43.88% |
| Jun 30, 2025 | -41.61% |
| Mar 31, 2025 | -39.99% |
| Mar 31, 2024 | -54.49% |
| Dec 31, 2023 | -54.39% |
| Sep 30, 2023 | -53.80% |
| Jun 30, 2023 | -52.95% |
| Mar 31, 2023 | -55.30% |
| Dec 31, 2022 | -65.44% |
| Sep 30, 2022 | -67.41% |
| Jun 30, 2022 | -57.37% |
| Mar 31, 2022 | -48.48% |
| Dec 31, 2021 | -42.62% |
| Sep 30, 2021 | -37.03% |
| Jun 30, 2021 | -35.40% |
| Mar 31, 2021 | -34.95% |
| Dec 31, 2020 | -33.48% |
API Access
Iovance Biotherapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=IOVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "IOVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=IOVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();